Talphera reports earnings on a quarterly basis. These quarterly earnings reports give investors a glimpse into financial results from a company for a 3 month period. Earnings reports almost always include EPS and Revenue results.
Analyze the earnings history of Talphera using advanced sorting and filters.
Get Alert | |||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|
TLPH | Talphera | -$0.15 | — | — | — | $0.00 | — | — | — | 08/13/2025 | Get Alert |
TLPH | Talphera | -$0.16 | -$0.14 | -$0.10 | 28.57% | $0.00 | — | $27.00K | — | 05/14/2025 | Get Alert |
TLPH | Talphera | -$0.25 | -$0.16 | -$0.07 | 56.25% | $281.00K | — | $0.00 | — | 03/31/2025 | Get Alert |
TLPH | Talphera | -$0.08 | -$0.20 | -$0.13 | 35.00% | $117.00K | — | $0.00 | — | 11/13/2024 | Get Alert |
TLPH | Talphera | -$0.40 | -$0.23 | -$0.15 | 34.78% | $253.00K | — | $0.00 | — | 08/14/2024 | Get Alert |
TLPH | Talphera | -$0.75 | -$0.22 | -$0.16 | 27.27% | $0.00 | — | $0.00 | — | 05/14/2024 | Get Alert |
TLPH | Talphera | -$1.00 | -$0.20 | -$0.25 | -25.00% | $252.00K | $280.00K | $281.00K | 0.36% | 03/06/2024 | Get Alert |
TLPH | AcelRx Pharmaceuticals | -$0.94 | -$0.28 | -$0.08 | 71.43% | $507.00K | $130.00K | $117.00K | -10.00% | 11/08/2023 | Get Alert |
TLPH | AcelRx Pharmaceuticals | -$1.20 | -$0.53 | -$0.40 | 24.53% | $570.00K | $70.00K | $253.00K | 261.43% | 08/10/2023 | Get Alert |
TLPH | Talphera | -$1.20 | -$0.78 | -$0.75 | 3.85% | $442.00K | — | $0.00 | — | 05/10/2023 | Get Alert |
TLPH | Talphera | -$1.20 | -$0.51 | -$1.00 | -96.08% | $2.00K | $4.50M | $252.00K | -94.40% | 03/30/2023 | Get Alert |
TLPH | AcelRx Pharmaceuticals | -$1.40 | -$1.20 | -$0.94 | 21.67% | $1.86M | $620.00K | $507.00K | -18.23% | 11/14/2022 | Get Alert |
TLPH | Talphera | -$1.60 | -$1.40 | -$1.20 | 14.29% | $443.00K | $550.00K | $570.00K | 3.64% | 08/11/2022 | Get Alert |
TLPH | Talphera | -$1.60 | -$1.20 | -$1.20 | 0.00% | $511.00K | $550.00K | $442.00K | -19.64% | 05/16/2022 | Get Alert |
TLPH | Talphera | -$2.00 | — | -$1.20 | — | $738.00K | $1.85M | $2.00K | -99.89% | 03/10/2022 | Get Alert |
TLPH | AcelRx Pharmaceuticals | -$2.00 | -$1.40 | -$1.40 | 0.00% | $1.37M | $1.90M | $1.86M | -2.00% | 11/15/2021 | Get Alert |
TLPH | Talphera | -$1.60 | -$1.60 | -$1.60 | 0.00% | $2.92M | $1.81M | $443.00K | -75.52% | 08/16/2021 | Get Alert |
TLPH | Talphera | -$4.00 | -$1.60 | -$1.60 | 0.00% | $386.00K | $1.06M | $511.00K | -51.79% | 05/17/2021 | Get Alert |
TLPH | AcelRx Pharmaceuticals | -$3.60 | -$2.00 | -$2.00 | 0.00% | $475.00K | $1.73M | $738.00K | -57.34% | 03/15/2021 | Get Alert |
TLPH | Talphera | -$3.20 | -$1.60 | -$2.00 | -25.00% | $608.00K | $2.83M | $1.37M | -51.66% | 11/05/2020 | Get Alert |
TLPH | Talphera | -$3.20 | -$2.80 | -$1.60 | 42.86% | $941.00K | $2.02M | $2.92M | 44.75% | 08/10/2020 | Get Alert |
Fiscal Quarter | Date Reported | Actual EPS | Estimated EPS | Surprise % |
---|---|---|---|---|
Q1 | 2025-05-14 | $-0.10 | $-0.14 | 28.6 % |
Q4 | 2025-03-31 | $-0.07 | $-0.16 | 56.3 % |
Q3 | 2024-11-13 | $-0.13 | $-0.20 | 35.0 % |
Q2 | 2024-08-14 | $-0.15 | $-0.23 | 34.8 % |
Fiscal Quarter | Date Reported | Actual Revenue | Estimated Revenue | Surprise % |
---|---|---|---|---|
Q4 | 2024-03-06 | $281.00K | $280.00K | 0.36 % |
Q3 | 2023-11-08 | $117.00K | $130.00K | -10.0 % |
Q2 | 2023-08-10 | $253.00K | $70.00K | 261.4 % |
Q4 | 2023-03-30 | $252.00K | $4.50M | -94.4 % |
Talphera (TLPH) is scheduled to report earnings on August 13, 2025. The last reported earnings were for reported on May 14, 2025 for Q1.
The Actual EPS was $-0.10, which beat the estimate of $-0.14.
The Actual Revenue was $27K, which beat the estimate of $0K.
Browse earnings estimates, EPS, and revenue on all stocks.